Orchid Pharma Ltd.

Orchid Pharma Ltd.

ORCHPHARMA

Orchid Pharma Ltd.

Orchid Pharma Ltd.

ORCHPHARMA

Orchid Pharma Ltd. Share Price

1,016.60 -21.50 (-2.07%)
Orchid Pharma 01 the leading ptlarrna<;eutlcal oompanies in India haad quartered In Channai and Involved in the davelopment, manufacture and marketing of diverse bulk aeWes. formulationS and nutraceu~cals with exports spanning over 40 counllies. Orcttid's world class manufacturing infrasl1uclure Include USFDA compliant API and Finished Dosage Form faciliUes at Chennai In India. OrctIid lias dediCilted stale-of-art and GLP compliant R&D infrastructure fOf Procen researetl, Drug Discovery and Pllarmaceut!cal researen at Chennal, India.
1,002.70Today's Low
1,043.95Today's High
480.0052W Low
1,133.0052W High

Fundamentals

Market Cap

₹6,014Cr

EPS

₹4.05

Book Value/Share

₹217.00

P/E Ratio (TTM)

606.97

Industry P/E (TTM)

46.90

P/B Ratio

4.39

Long Term D/E

0.28

ROE

1.65%

Dividend Yield (TTM)

0.00%

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Very Expensive

Average Quality

Low Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Orchid Pharma Ltd.

The share price of Orchid Pharma Ltd. is ₹1,016.60 on NSE as of 25/8/2026, 11:53:05 am. Share prices may change frequently due to market movements.

The market capitalisation of Orchid Pharma Ltd. is ₹6,014Cr as of 25/8/2026, 11:53:05 am

The current Price to Earnings (P/E) ratio of Orchid Pharma Ltd. is 606.97 as of 25/8/2026, 11:53:05 am

The Price to Book (P/B) ratio of Orchid Pharma Ltd. stands at 4.39 as of 25/8/2026, 11:53:05 am

Orchid Pharma Ltd. reported an ROE of 1.65% for the last reported financial year on a consolidated account basis.

As of 25/8/2026, 11:53:05 am, Orchid Pharma Ltd.’s shareholding pattern is: promoters hold 69.80%, FIIs hold 0.80%, DIIs hold 0.90%, and public shareholders hold 8.60%.

The 52-week high of Orchid Pharma Ltd. is ₹1,043.95 and the 52-week low is ₹1,002.70 as of 25/8/2026, 11:53:05 am.

The earnings per share (EPS) of Orchid Pharma Ltd. is ₹0.54 for the quarter ended Jun 2026.

The stock symbol of Orchid Pharma Ltd. is ORCHPHARMA.

You can buy Orchid Pharma Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Orchid Pharma Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue304.17+28.01%
Other Income1.83-75.07%
Total Income306.00+24.92%
Total Expenditure290.17+37.69%
EBIDT15.83-54.45%
Depreciation10.95+23.45%
Interest2.23-27.83%
Tax0.07-
Net Profit3.22-86.46%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets683.90
Total Non-Current Assets1,227.01
Fixed assets1,027.42
Total Assets1,910.91
Total Current liabilities278.97
Total Non Current Liabilities344.16
Total Equity Plus Liabilities1,910.91
Total Shareholder Funds1,287.78
Total Debt to Equity28.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity101.20
Cash from Financing Activities169.98
Cash from Investing Activities-285.27
Net Cash Flow-14.10

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages7

Bearish Moving Averages9

5 Day

993.80

10 Day

1,018.90

20 Day

1,011.40

30 Day

1,017.10

50 Day

1,004.30

100 Day

837.40

150 Day

767.00

200 Day

778.30

Indicators

RSI (14)

55.98

MACD (12, 26)

5.00

MACD Signal Line (9)

9.07

MFI (14)

63.11

ATR (14)

48.49

ADX (14)

21.03

ROC (21)

5.01

ROC (125)

56.28

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic1,059.731,081.371,113.731,027.371,005.73973.37951.73

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages7

Bearish Moving Averages9

5 Day

993.80

10 Day

1,018.90

20 Day

1,011.40

30 Day

1,017.10

50 Day

1,004.30

100 Day

837.40

150 Day

767.00

200 Day

778.30

Indicators

RSI (14)

55.98

MACD (12, 26)

5.00

MACD Signal Line (9)

9.07

MFI (14)

63.11

ATR (14)

48.49

ADX (14)

21.03

ROC (21)

5.01

ROC (125)

56.28

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic1,059.731,081.371,113.731,027.371,005.73973.37951.73

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Orchid Pharma Ltd.

Orchid Pharma Ltd.

ORCHPHARMA

Open Price

1,039.50

Prev Close

1,038.10

Upper Circuit

1,245.70

Lower Circuit

830.50

Volume

20,157

Average Traded Price

1,018.09
1,002.70Today's Low
1,043.95Today's High
480.0052W Low
1,133.0052W High

Historical Performance

1 DayNA
5 DaysNA
1 MonthNA
3 MonthsNA
1 YearNA
5 YearsNA
10 YearsNA
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.